Forms of rifaximin and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9034892
APP PUB NO 20140141081A1
SERIAL NO

13929003

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to Rifaximin polymorphic, salt, hydrate, and amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SALIX PHARMACEUTICALS INC400 SOMERSET CORPORATE BLVD BRIDGEWATER NJ 08807

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gushurst, Karen S West Lafayette, US 15 146
Stults, Jeffrey S Lafayette, US 38 197
Vlahova, Petinka West Lafayette, US 17 138
Yang, Donglai Annandale, US 19 142

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 19, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00